Ayala Pharmaceuticals Book/Share
What is the Book/Share of Ayala Pharmaceuticals?
The Book/Share of Ayala Pharmaceuticals Inc. is 5.20
What is the definition of Book/Share?
Book value per share is a company’s assets minus liabilities divided by the number of shares outstanding.
mrq (most recent quarter)
The book value of a company is the value of its assets according to its balance sheet account balance. For assets, the value is based on the original cost of the asset less any depreciation, amortization or impairment costs made against the asset. Traditionally, a company's book value is its total assets minus intangible assets and liabilities. However, in practice, depending on the source of the calculation, book value may variably include goodwill, intangible assets, or both. The value inherent in its workforce, part of the intellectual capital of a company, is always ignored. The book value of a company may be also referred as with the term net asset value.
The book value per share is the the balance sheet equity value divided by the number of shares outstanding at the date of the balance sheet. Book value per share can be used to generate a measure of comprehensive earnings, when the opening and closing values are reconciled. The sale of shares/units by a business increases the total book value. Book value per share will increase if the additional shares are issued at a price higher than the pre-existing book value per share. The purchase of its own shares by a business will decrease total book value. Book value per share will decrease if more is paid for them than was received when originally issued. Dividends paid out will decrease book value per share value.
Book/Share of companies in the Health Care sector on NASDAQ compared to Ayala Pharmaceuticals
What does Ayala Pharmaceuticals do?
advaxis (nasdaq: adxs) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. the advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.
Companies with book/share similar to Ayala Pharmaceuticals
- Duff & Phelps Select MLP and Midstream Fund Inc has Book/Share of 5.20
- X-FAB Silicon Foundries SE has Book/Share of 5.20
- Estee Lauder Cos has Book/Share of 5.20
- China Zhongwang has Book/Share of 5.20
- Syncora has Book/Share of 5.20
- Bank Of South Carolina has Book/Share of 5.20
- Ayala Pharmaceuticals has Book/Share of 5.20
- Canadian Net Real Estate Investment Trust has Book/Share of 5.21
- Corticeira Amorim SGPS SA has Book/Share of 5.21
- FAX Capital has Book/Share of 5.21
- China Customer Relations Centers Inc has Book/Share of 5.21
- Elate has Book/Share of 5.21
- Elders has Book/Share of 5.22